Open, Two Periods, Two Treatments, Two Sequences, Cross-over, Randomized Study With Single Dosage of Two Oral Preparations in Tablets Containing Escitalopram 10 mg (Product From GlaxoSmithKline Mexico, S.A. de C.V. vs. Lexapro 10mg, Lundbeck Mexico, S.A. de C.V.) in Fasting Healthy Volunteers
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Escitalopram (Primary)
- Indications Generalised anxiety disorder; Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Social phobia
- Focus Pharmacokinetics
- 16 Jun 2017 Biomarkers information updated
- 11 Jan 2013 New trial record